Jacquin-Piques Agnès, Sacco Guillaume, Tavassoli Neda, Rouaud Olivier, Bejot Yannick, Giroud Maurice, Robert Philippe, Vellas Bruno, Bonin-Guillaume Sylvie
University Hospital of Dijon, Centre Mémoire de Ressources et de Recherches, Department of Neurology, Dijon, France.
Centre Mémoire de Ressource et de Recherche, EA CoBTeK, Université de Nice Sophia-Antipolis, Nice, France.
J Alzheimers Dis. 2016;49(3):671-80. doi: 10.3233/JAD-150280.
Psychotropic drugs are frequently prescribed in nursing homes (NH). Nonetheless, we hoped that institutionalization decreases the number of psychotropic drug classes prescribed, because NH residents may have more psychosocial interventions than patients living at home.
The aim was to compare the type and number of psychotropic drugs prescribed in elderly NH residents with dementia with those in community-living patients.
This cross-sectional study included elderly patients (at least 75 years old) with dementia recorded in the National Alzheimer's data Bank ("Banque Nationale Alzheimer") during the year 2012 and who were taking at least one psychotropic drug. Psychotropic drugs were classified as follows: antidepressant, anxiolytic, hypnotic, and antipsychotic drugs. Patients were classified into three categories of dementia severity according to the MMSE score.
Among the 50,932 patients with dementia recorded in the BNA, 40.1% had at least one psychotropic drug prescribed. Most of the patients who were treated by at least one psychotropic drug class had antidepressant therapy (69.0%), whatever their residence type, and 16.1% were treated with antipsychotics. Among the study population, 51.9% of the NH residents and 67.4% of the patients living at home had only one psychotropic drug class prescribed. Living in a NH was significantly associated with the more frequent prescription of anxiolytic, hypnotic, and antipsychotic drugs, and with a greater number of psychotropic drug classes prescribed, whatever the severity of the dementia.
We underlined the more frequent prescription of psychotropic drugs in NH residents regardless of MMSE scores.
精神药物在疗养院(NH)中经常被开具处方。尽管如此,我们希望机构化能减少所开具的精神药物种类数量,因为疗养院居民可能比居家患者接受更多的心理社会干预。
目的是比较患有痴呆症的老年疗养院居民与社区居住患者所开具的精神药物的类型和数量。
这项横断面研究纳入了2012年在国家阿尔茨海默病数据库(“Banque Nationale Alzheimer”)中记录的、至少服用一种精神药物的75岁及以上患有痴呆症的老年患者。精神药物分类如下:抗抑郁药、抗焦虑药、催眠药和抗精神病药。根据简易精神状态检查表(MMSE)评分,将患者分为痴呆严重程度的三类。
在BNA记录的50932例痴呆患者中,40.1%至少开具了一种精神药物处方。无论居住类型如何,大多数接受至少一种精神药物治疗的患者都接受了抗抑郁治疗(69.0%),16.1%接受了抗精神病药物治疗。在研究人群中,51.9%的疗养院居民和67.4%的居家患者仅开具了一种精神药物。无论痴呆严重程度如何,居住在疗养院与更频繁地开具抗焦虑药、催眠药和抗精神病药以及开具更多种类的精神药物显著相关。
我们强调了无论MMSE评分如何,疗养院居民中精神药物的处方更为频繁。